Top compounds associated with response to MTHFSD


Feature Type Standardized
Nominal ANOVA
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.068 0.06
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.056 0.07
mRNA Cyclopamine FIMM pan-cancer AAC 0.27 0.07
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.2 0.07
mRNA narciclasine CTRPv2 pan-cancer AAC -0.061 0.07
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.061 0.07
mRNA SB 505124 GDSC1000 pan-cancer AAC 0.063 0.07
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.07
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.078 0.08
mRNA Docetaxel gCSI pan-cancer AAC -0.098 0.08
Download CSV